The pathogenesis of antiphospholipid syndrome, a heterogeneous vascular disease characterized by the occurrence of thrombotic and/or obstetrical events in various vascular tissues, requires antiphospholipid antibodies among which anti-β2 glycoprotein I antibodies (GP1) provide the main pathogenic subset. Here, GTPBP1 is linked to antiphospholipid syndrome.